Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord

Journal of Neuroimmunology

Volumn 219, Issue 1-2, 2010, Pages 33-37

  Nikodemova, Maria ^a   Lee, JangEun ^b   Fabry, Zsuzsanna ^b   Duncan, Ian D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cytokines; EAE; Minocycline; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MINOCYCLINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD; BODY WEIGHT; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MINOCYCLINE; RATS; SPINAL CORD; T-LYMPHOCYTES;

EID: 77249130232     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.11.009     Document Type: Article

References (14)

1. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125:1297-1308.
2. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U S A 2001, 98:14669-14674.
3. Dugger K.J., Zinn K.R., Weaver C., Bullard D.C., Barnum S.R. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2009, 206:22-27.
4. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
5. Lee J., Reinke E.K., Zozulya A.L., Sandor M., Fabry Z. Mycobacterium bovis bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J. Immunol. 2008, 181:6201-6212.
6. Metz L.M., Zhang Y., Yeung M., Patry D.G., Bell R.B., Stoian C.A., Yong V.W., Patten S.B., Duquette P., Antel J.P., Mitchell J.R. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 2004, 55:756.
7. Nikodemova M., Watters J.J., Jackson S.J., Yang S.K., Duncan I.D. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J. Biol. Chem. 2007, 282:15208-15216.
8. Paemen L., Martens E., Norga K., Masure S., Roets E., Hoogmartens J., Opdenakker G. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem. Pharmacol. 1996, 52:105-111.
9. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol. 2002, 51:215-223.
10. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of T(H)-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009.
11. Wilkins A., Nikodemova M., Compston A., Duncan I. Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro. Neuron Glia Biol. 2004, 1:297-305.
12. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U S A 1998, 95:15769-15774.
13. Zhang Y., Metz L.M., Yong V.W., Bell R.B., Yeung M., Patry D.G., Mitchell J.R. Pilot study of minocycline in relapsing-remitting multiple sclerosis. Can. J. Neurol. Sci. 2008, 35:185-191.
14. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.